Now showing items 1-1 of 1
Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function
(Wiley Subscription Services, Inc., A Wiley Company, 1988-06)
Fifteen drug-free patients with early to mid-stage Huntington's disease (HD) were evaluated with positron emission tomographic (PET) scans of 18 F-2-fluro-2-deoxy- D -glucose uptake and quantitative measures of neurological ...